G. Maiti et al. / Tetrahedron Letters 54 (2013) 2920–2923
2923
5. (a) Selvi, G.; Rajendran, S. P. J. Asian Chem. 2004, 16, 1017–1022; (b) Bahuguna,
R. P.; Joshi, B. C. Indian J. Heterocycl. Chem. 1994, 3, 265–268.
6. Szmuszkovicz, J.; Darlington, W. H.; Von Voigtlander, P. F. WO 8804292 A1,
Chem. Abstr. 1988, 110, 75335.
7. Nozulak, J.; Vigouret, J. M.; Jaton, A. L.; Hofmann, A.; Dravid, A. R.; Weber, H. P.;
Kalkman, H. O.; Walkinshaw, M. D. J. Med. Chem. 1992, 35, 480–489.
8. Mikhailitsyn, F. S.; Kozyreva, N. P.; Rabinovich, S. A.; Maksakovskaya, Y. V.;
Kulikovskaya, I. M.; Dadasheva, N. R.; Lebedeva, M. N.; Bekhli, A. F.; Lychko, N.
D.; Uvarova, N. A. Med. Parazitol. Parazit. Bolezni. 1992, 50–53. Chem. Abstr.
1992, 117, 251317.
9. (a) Schmittel, M.; Ammon, H. Eur. J. Org. Chem. 1998, 785–792; (b) Gladiali, S.;
Chelucci, G.; Mudadu, M. S.; Gastaut, M.-A.; Thummel, R. P. J. Org. Chem. 2001,
66, 400–405.
(h) Garc´ia, A.-B.; Valdés, C.; Cabal, M.-P. Tetrahedron Lett. 2004, 45, 4357–4360;
(i) Danieli, B.; Lesma, G.; Passarella, D.; Piacenti, P.; Sacchetti, A.; Silvani, A.;
Virdis, A. Tetrahedron Lett. 2002, 43, 7155–7158.
16. Wang, X. S.; Zhou, J.; Yang, K.; Yao, C. S. Tetrahedron Lett. 2010, 51, 5721–5723.
and reference cited therein.
17. Maiti, G.; Kundu, P. Tetrahedron Lett. 2006, 47, 5733–5736.
18. (a) Maiti, G.; Karmakar, R.; Bhattacharya, R. N.; Kayal, U. Tetrahedron Lett. 2011,
52, 5610–5612; (b) Maiti, G.; Kayal, U.; Karmakar, R.; Bhattacharya, R. N.
Tetrahedron Lett. 2012, 53, 1460–1463.
19. (a) Mazieres, S.; Roux, L. C.; Peyronneau, M.; Gornitzka, H.; Roques, N. Eur. J.
Inorg. Chem. 2004, 2823–2826; (b) Wu, Q.; Wang, Y.; Chen, W.; Liu, H. Synth.
Commun. 2006, 36, 1361–1366; (c) Gania, A. B.; Kumar, S.; Andotra, S. C.;
Kapoor, K. K. Synth. Commun. 2006, 36, 803–807; (d) Goudara, M. A.;
Jayadevappab, H.; Sudhakara, A.; Mahadevan, K. M. Lett. Org. Chem. 2008, 5,
628–632; (e) Bhattacharya, R. N.; Kundu, P.; Maiti, G. Synth. Commun. 2010, 40,
476–481; (f) Bhattacharya, R. N.; Kundu, P.; Maiti, G. Tetrahedron Lett. 2011, 52,
26–28.
10. (a) Carr, B. A.; Franklin, M. R. Xenobiotica 1998, 28, 949–956; (b) Le, H. T.; Lamb,
J. G.; Franklin, M. R. J. Biochem. Toxicol. 1996, 11, 297–303.
11. (a) Harrowven, D. C.; Sutton, B. J.; Coulton, S. Tetrahedron Lett. 2001, 42, 2907–
2910; (b) Campos, P. J.; Anon, E.; Malo, M. C.; Tan, C.-Q.; Rodriguez, M. A.
Tetrahedron 1998, 54, 6929–6938; (c) Pratap, R.; Ram, V. J. Tetrahedron Lett.
2007, 48, 2755–2759; (d) Mamane, V.; Louërat, F.; Iehl, J.; Abboud, M.; Fort, Y.
Tetrahedron 2008, 64, 10699–10705; (e) Kise, N.; Isemoto, S.; Sakurai, T. Org.
Lett. 2009, 11, 4902–4905; (f) Aramoto, H.; Obora, Y.; Ishii, Y. J. Org. Chem. 2009,
74, 628–633.
12. (a) Daly, J. W.; Spande, T. F. In Alkaloids: Chemical and Biological Perspectives;
Pelletier, S. W., Ed.; Wiley: New York, NY, 1986; 4, pp 1–254; (b) Fodor, G. B.;
Colasanti, B. In Alkaloids: Chemical and Biological Perspectives; Pelletier, S. W.,
Ed.; Wiley: New York, NY, 1985; 3, pp 1–91.
13. (a) Boger, D. L.; Patel, M. Prog. Heterocycl. Chem. 1989, 1, 1–30; (b) Suschitzky,
H., Scriven, E. F. V., Eds.; Pergamon: New York, NY, 1989, 1, 1-30.; (c) Kametani,
T.; Hibino, S. Adv. Heterocycl. Chem. 1987, 42, 246–333.
14. (a) Buonora, P.; Olsen, J. C.; Oh, T. Tetrahedron 2001, 57, 6099–6138; (b)
Jørgensen, K. A. Angew. Chem., Int. Ed. 2000, 39, 3558–3588.
15. (a) Bhargava, G.; Mohan, C.; Mahajan, M. P. Tetrahedron 2008, 64, 3017–3024;
(b) Takasu, K.; Shindoh, N.; Tokuyama, H.; Ihara, M. Tetrahedron 2006, 62,
11900–11907; (c) Manian, R. D. R. S.; Jayashankaran, J.; Ramesh, R.;
Raghunathan, R. Tetrahedron Lett. 2006, 47, 7571–7574; (d) Yadav, J. S.;
Reddy, B. V. S.; Kondaji, G.; Sowjanya, S.; Nagaiah, K. J. Mol. Catal. A: Chem.
2006, 258, 361–366; (e) Prenzel, A. H. G. P.; Deppermann, N.; Maison, W. Org.
Lett. 2006, 8, 1681–1684; (f) Zhou, Y.; Jia, X.; Li, R.; Liu, Z.; Liu, Z.; Wu, L.
Tetrahedron Lett. 2005, 46, 8937–8939; (g) Rodr´iguez, M.; Ochoa, M. E.;
Santillan, R.; Farfán, N.; Barba, V. J. Organomet. Chem. 2005, 690, 2975–2988;
20. Representative experimental procedure for the synthesis of dimethyl 3-phenyl-3,4-
dihydrobenzo[f]quinoline-1,2-dicarboxylate (4a): A magnetically stirred mixture
of benzaldehyde (100 mg, 1.0 mmol), naphthalene-2-amine (134 mg,
1.0 mmol), dimethyl acetylene dicarboxylate (159 mg, 1.2 mmol), and
anhydrous antimony trichloride (22 mg, 0.10 mmol) in dry acetonitrile
(3 mL) under argon was refluxed for 6 h (monitored by TLC). The solvent was
removed under reduced pressure and the residue obtained was purified by
column chromatography over silica gel (18% ethyl acetate in petroleum ether)
yielded 4a (315 mg, 80%) and 5a (39 mg, 10%). Compound 4a, mp 210 °C; IR
(KBr): 3342, 2950, 1718, 1702, 1619, 1604, 1561, 1431, 1237, 1205, 1097,
821,754 cmÀ1 1H NMR (300 MHz, CDCl3): d 3.79 (s, 3H), 3.95 (s, 3H), 5.64 (br s,
.
1H), 6.80 (d, J = 8.7 Hz, 1H), 7.20–7.26 (m, 4H), 7.37 (m, 3H), 7.61 (t, J = 9.0 Hz,
2H), 7.84 (d, J = 8.7 Hz, 1H). 13C NMR (CDCl3, 75 MHz): d 52.3, 52.5, 52.7, 109.8,
114.9, 116.9, 122.1, 122.9, 126.3, 127.7, 127.8, 128.3, 128.5, 129.2, 131.5, 134.0,
139.6, 141.8, 144.5, 165.0, 170.4. HRMS (ES+): calcd for [C23H19NO4] Na+:
396.1206; found: 396.1202. Compound 5a (39 mg, 10%), mp: 147–148 °C; IR
(KBr): 2956, 1747, 1718, 1548, 1443, 1435, 1241, 1005, 964, 842, 811, 766,
740 cmÀ1 1H NMR (300 MHz, CDCl3): d 3.71 (s, 3H), 4.10 (s, 3H), 7.48–7.51 (m,
.
3H), 7.64–7.68 (m, 2H), 7.70–7.73 (m, 2H), 7.94–7.97 (m, 1H), 8.06 (s, 2H),
8.27–8.30 (m, 1H). 13C NMR (CDCl3, 75 MHz): d 52.9, 53.5, 119.5, 124.2, 125.2,
127.4, 127.9, 128.2, 128.3, 128.5, 129.1, 129.4, 132.9, 133.5, 138.4, 139.6, 149.7,
156.0, 168.3, 169.6. HRMS (ES+): calcd for [C23H17NO4] Na+: 394.1050; found:
394.1053.